Mark Verratti - Mar 15, 2023 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Chief Commercial Officer
Signature
By: Justin Hunter For: Mark Verratti
Stock symbol
MYGN
Transactions as of
Mar 15, 2023
Transactions value $
$0
Form type
4
Date filed
3/16/2023, 04:29 PM
Previous filing
Oct 11, 2022
Next filing
Mar 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Award $0 +39.4K +17.28% $0.00 267K Mar 15, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.